About Epistemix
Epistemix is a Healthcare company based in Pittsburgh (United States) founded in 2018. Population management software is offered for healthcare providers. Epistemix has raised $11.62 million across 3 funding rounds from investors including Ecliptic Capital. The company has 11 employees. Epistemix offers products and services including Consumer Insights Platform, Forecasting Service, and Scenario Planning Tool. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Population Health Management. Its legal entity is EPISTEMIX, INC. Its competitors include Color, Unite Us and Biobot Analytics; 3 of its 3 listed competitors have raised funding.
Company details
Epistemix was founded in 2018 in Pittsburgh, United States, and operates in the healthcare software sector. Online tools are provided for population management, including disease management and community health programs. Services encompass status report generation, computational analysis, and health tracking for government medical organizations, health systems, enterprises, and institutions. The platform supports various healthcare entities through its digital features.
- Headquarters Pittsburgh, United States
- Employees 11
- SectorsHealthcare
- Email••••••••
- Website epistemix.com
- Social LinkedIn X
- Legal Name Epistemix, Inc.
- Total Equity Funding$11.62M (USD)
in 3 rounds
- Latest Funding Round$5M (USD), Series A
Apr 2024
- Investors
- Employee Count11
Products & Services of Epistemix
Epistemix offers a comprehensive portfolio of products and services, including Consumer Insights Platform, Forecasting Service, and Scenario Planning Tool.
Overlays data on synthetic populations for market segmentation.
Identifies trends using population models for strategic planning.
Tests scenarios via AI to minimize decision-making risks.
Funding Insights of Epistemix
Epistemix has successfully raised a total of $11.62M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.62M
- Total Rounds 3
- Last Round Series A — $5M
- First Round $1.63M
(Apr 2021)
- Investors Count 1
All 3 funding rounds of Epistemix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $5M | Series A | – | – | – |
| Mar 2022 | $5M | Seed | – | Ecliptic Capital | – |
| Apr 2021 | $1.63M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Epistemix
Epistemix has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ecliptic Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ecliptic.capital |
Investor details for Epistemix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Epistemix
2 people are tracked at Epistemix (2 in leadership); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Andrew Lane | Director of Data Science | Leadership |
John Cordier | Chief Executive Officer | Leadership |
Complete people profiles for Epistemix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Epistemix
3 dated milestones of Epistemix across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Epistemix is founded.
- Funding First funding round of $1.6M.
- Funding Latest funding round, Series A, of $5.0M.
Competitors of Epistemix
Epistemix has 3 listed competitors in our database, 3 of them funded. They include Color, Unite Us and Biobot Analytics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| uniteus.com | 2013 | New York, United States | $195.53M | Cloud-based software for patient interoperability and community management is offered. | ||
| biobot.io | 2017 | Cambridge, United States | $42.69M | 98 | Tools are provided to map microbes and chemicals of interest. |
Detailed competitors of Epistemix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Epistemix
The website of Epistemix (epistemix.com) receives about 7.8K visits a month.
- Monthly visits7.8K
▲ 11.8% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Epistemix (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Epistemix
Complete news archive for Epistemix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epistemix
Epistemix was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Epistemix is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Epistemix is a funded company, having raised a total of $11.62M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.63M, raised on Apr 2021.
Epistemix has 11 employees.
Epistemix was founded in 2018 in Pittsburgh, United States, and operates in the healthcare software sector. Online tools are provided for population management, including disease management and community health programs. Services encompass status report generation, computational analysis, and health tracking for government medical organizations, health systems, enterprises, and institutions. The platform supports various healthcare entities through its digital features.
Epistemix's top competitors include Biobot Analytics, Unite Us and Color.
Epistemix offers Consumer Insights Platform, Forecasting Service, and Scenario Planning Tool.
Epistemix has 1 investor. Key investors include Ecliptic Capital.
Epistemix operates through Epistemix, Inc..